story of the week
Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial
J. Clin. Oncol 2019 Oct 28;[EPub Ahead of Print], P Sharma, WE Barlow, AK Godwin, EE Parkes, LA Knight, SM Walker, RD Kennedy, DP Harkin, GE Logan, CJ Steele, SM Lambe, S Badve, Y Gökmen-Polar, HB Pathak, K Isakova, HM Linden, P Porter, L Pusztai, AM Thompson, D Tripathy, GN Hortobagyi, DF HayesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.